Jim C. Gourdon

1.1k total citations
42 papers, 870 citations indexed

About

Jim C. Gourdon is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Jim C. Gourdon has authored 42 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 14 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Jim C. Gourdon's work include Neuroscience and Neuropharmacology Research (26 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Jim C. Gourdon is often cited by papers focused on Neuroscience and Neuropharmacology Research (26 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Jim C. Gourdon collaborates with scholars based in Canada, United States and Cameroon. Jim C. Gourdon's co-authors include Jennifer M. Wright, Paul B. S. Clarke, Philippe Huot, Stephen G. Nuara, Adjia Hamadjida, Dominique Bédard, Cynthia Kwan, Imane Frouni, Francis Beaudry and Fleur Gaudette and has published in prestigious journals such as The FASEB Journal, Neuroscience and Journal of Neurochemistry.

In The Last Decade

Jim C. Gourdon

41 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jim C. Gourdon Canada	18	382	211	169	125	120	42	870
Olga L. Lopatina Russia	25	229 0.6×	497 2.4×	61 0.4×	146 1.2×	346 2.9×	96	1.5k
Cristina Cocco Italy	20	210 0.5×	267 1.3×	143 0.8×	27 0.2×	207 1.7×	44	974
Carolyn B. Boylan United States	11	692 1.8×	135 0.6×	127 0.8×	153 1.2×	188 1.6×	14	940
Adam Hamed Poland	17	430 1.1×	318 1.5×	41 0.2×	157 1.3×	155 1.3×	33	847
QiLiang Chen United States	13	205 0.5×	281 1.3×	74 0.4×	241 1.9×	126 1.1×	27	851
Valentina Chiodi Italy	16	263 0.7×	186 0.9×	50 0.3×	74 0.6×	226 1.9×	25	860
Natallia V. Riddick United States	17	261 0.7×	238 1.1×	32 0.2×	210 1.7×	299 2.5×	21	849
Denise I. Briggs United States	15	308 0.8×	156 0.7×	350 2.1×	194 1.6×	328 2.7×	17	1.2k
Paweł M. Boguszewski Poland	19	350 0.9×	352 1.7×	44 0.3×	314 2.5×	227 1.9×	35	1.0k
Mareike Voget Germany	9	121 0.3×	157 0.7×	74 0.4×	80 0.6×	82 0.7×	10	579

Countries citing papers authored by Jim C. Gourdon

Since Specialization

Citations

This map shows the geographic impact of Jim C. Gourdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim C. Gourdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim C. Gourdon more than expected).

Fields of papers citing papers by Jim C. Gourdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim C. Gourdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim C. Gourdon. The network helps show where Jim C. Gourdon may publish in the future.

Co-authorship network of co-authors of Jim C. Gourdon

This figure shows the co-authorship network connecting the top 25 collaborators of Jim C. Gourdon. A scholar is included among the top collaborators of Jim C. Gourdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim C. Gourdon. Jim C. Gourdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frouni, Imane, Cynthia Kwan, Dominique Bédard, et al.. (2024). Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(11). 9135–9147. 2 indexed citations

Frouni, Imane, Dominique Bédard, Cynthia Kwan, et al.. (2024). Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(11). 8917–8924. 1 indexed citations

Nuara, Stephen G., Dominique Bédard, Imane Frouni, et al.. (2023). The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(10). 2347–2355. 5 indexed citations

Kwan, Cynthia, Imane Frouni, Dominique Bédard, et al.. (2023). The 5‐HT_2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmoset. European Journal of Neuroscience. 59(6). 1169–1176. 3 indexed citations

Nuara, Stephen G., Jim C. Gourdon, & Philippe Huot. (2022). Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset. Pharmacological Reports. 74(4). 614–625. 5 indexed citations

Frouni, Imane, Cynthia Kwan, Adjia Hamadjida, et al.. (2022). Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset. European Journal of Pharmacology. 939. 175429–175429. 4 indexed citations

Nuara, Stephen G., Jim C. Gourdon, Shawn P. Maddaford, & Philippe Huot. (2021). Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(12). 2381–2388. 3 indexed citations

Hamadjida, Adjia, Stephen G. Nuara, Dominique Bédard, et al.. (2020). Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset. European Journal of Pharmacology. 873. 172957–172957. 25 indexed citations

Kwan, Cynthia, Stephen G. Nuara, Dominique Bédard, et al.. (2020). Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset. Neuropharmacology. 182. 108386–108386. 13 indexed citations

10.

Nuara, Stephen G., Adjia Hamadjida, Jim C. Gourdon, & Philippe Huot. (2020). The mGlu2/3 antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu2 activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmoset. Journal of Neural Transmission. 127(7). 1013–1021. 9 indexed citations

11.

Hamadjida, Adjia, Stephen G. Nuara, Cynthia Kwan, et al.. (2020). Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(11). 2157–2164. 2 indexed citations

12.

Gaudette, Fleur, Adjia Hamadjida, Dominique Bédard, et al.. (2018). Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset. Journal of Chromatography B. 1093-1094. 1–7. 17 indexed citations

13.

Kwan, Cynthia, Imane Frouni, Dominique Bédard, et al.. (2018). 5-HT2A blockade for dyskinesia and psychosis in Parkinson’s disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review. Experimental Brain Research. 237(2). 435–442. 27 indexed citations

14.

Gutierrez, Karina, Werner Giehl Glanzner, Rodrigo Camponogara Bohrer, et al.. (2017). The effect of age and length of gonadotropin stimulation on the in vitro embryo development of Holstein calf oocytes. Theriogenology. 104. 87–93. 38 indexed citations

15.

Camateros, Pierre, Cynthia Kanagaratham, Lukáš Najdekr, et al.. (2017). Toll-Like Receptor 7/8 Ligand, S28463, Suppresses Ascaris suum –induced Allergic Asthma in Nonhuman Primates. American Journal of Respiratory Cell and Molecular Biology. 58(1). 55–65. 5 indexed citations

16.

Hamadjida, Adjia, Stephen G. Nuara, Jim C. Gourdon, & Philippe Huot. (2017). The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 81. 367–371. 27 indexed citations

17.

Hamadjida, Adjia, Stephen G. Nuara, Imane Frouni, et al.. (2017). The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset. Psychopharmacology. 234(6). 905–911. 36 indexed citations

18.

Hamadjida, Adjia, Stephen G. Nuara, Jim C. Gourdon, & Philippe Huot. (2017). Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson’s disease. Journal of Neural Transmission. 125(9). 1355–1360. 27 indexed citations

19.

Wright, Jennifer M., Jim C. Gourdon, & Paul B. S. Clarke. (2010). Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context. Psychopharmacology. 211(1). 1–13. 265 indexed citations

20.

Dion, Yves-Marie, et al.. (2003). Totally Laparoscopic Juxtarenal Aortic Anastomosis. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 13(2). 111–114. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact